Full coverage· Economy· Updated
Sheba Sells Innovation Arm ARC to Redesign Health
The deal will transfer management of ARC's global network and rights to establish new innovation centers to Redesign Health, while ARC continues to operate existing centers and retain portfolio stakes.
2 newsrooms · 1 language · since
Plus
What happened
- 01ARC will continue operating innovation centers globally, but management and expansion rights transfer to Redesign Health.
- 02The deal aims to combine Sheba's clinical capabilities with Redesign Health's expertise in company building and investment.
- 03ARC currently supports over 130 startups with a portfolio valued at $6.7 billion.
- 04The President of ARC Global will become Vice Chairman of Redesign Health post-merger.
- 05Prof. Yitzhak Kreiss emphasized innovation's role in economic growth and healthcare resilience.
This merger aims to leverage Sheba's clinical expertise with Redesign Health's business development capabilities to accelerate healthcare innovation. Prof. Yitzhak Kreiss highlighted Sheba's commitment to innovation as a driver of economic growth and resilience.
The coverage
2 newsrooms on this story
Who covered it
- LeftNone
- CentreNone
- RightNone
- HarediNone
- ArabNone
- Other2
How it broke
See which of the 2 newsrooms broke it, and who waited